TR199900140T2 - 5HT2C antagonist ve bir D2 antagonist ihtiva eden farmas�tik bile�imi. - Google Patents

5HT2C antagonist ve bir D2 antagonist ihtiva eden farmas�tik bile�imi.

Info

Publication number
TR199900140T2
TR199900140T2 TR1999/00140T TR9900140T TR199900140T2 TR 199900140 T2 TR199900140 T2 TR 199900140T2 TR 1999/00140 T TR1999/00140 T TR 1999/00140T TR 9900140 T TR9900140 T TR 9900140T TR 199900140 T2 TR199900140 T2 TR 199900140T2
Authority
TR
Turkey
Prior art keywords
antagonist
5ht2c
pharmaceutical composition
compounds
activity
Prior art date
Application number
TR1999/00140T
Other languages
English (en)
Turkish (tr)
Inventor
Thomas Paul Blackburn Dr.
Original Assignee
Smithkline Beecham P.L.C.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Smithkline Beecham P.L.C. filed Critical Smithkline Beecham P.L.C.
Publication of TR199900140T2 publication Critical patent/TR199900140T2/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/445—Non condensed piperidines, e.g. piperocaine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/55—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia

Landscapes

  • Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Psychiatry (AREA)
  • Neurology (AREA)
  • Organic Chemistry (AREA)
  • Neurosurgery (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
TR1999/00140T 1996-07-26 1997-07-22 5HT2C antagonist ve bir D2 antagonist ihtiva eden farmas�tik bile�imi. TR199900140T2 (xx)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GBGB9615767.2A GB9615767D0 (en) 1996-07-26 1996-07-26 Novel treatment

Publications (1)

Publication Number Publication Date
TR199900140T2 true TR199900140T2 (xx) 1999-03-22

Family

ID=10797573

Family Applications (1)

Application Number Title Priority Date Filing Date
TR1999/00140T TR199900140T2 (xx) 1996-07-26 1997-07-22 5HT2C antagonist ve bir D2 antagonist ihtiva eden farmas�tik bile�imi.

Country Status (19)

Country Link
EP (1) EP0936924A2 (xx)
JP (1) JP2000516924A (xx)
KR (1) KR20000029564A (xx)
CN (1) CN1230894A (xx)
AR (1) AR008083A1 (xx)
AU (1) AU725817B2 (xx)
BR (1) BR9710568A (xx)
CA (1) CA2261813A1 (xx)
CO (1) CO5031292A1 (xx)
CZ (1) CZ23799A3 (xx)
GB (1) GB9615767D0 (xx)
HU (1) HUP9903619A3 (xx)
IL (1) IL128219A0 (xx)
NO (1) NO990322L (xx)
NZ (1) NZ333813A (xx)
PL (1) PL331426A1 (xx)
TR (1) TR199900140T2 (xx)
WO (1) WO1998004289A2 (xx)
ZA (1) ZA976593B (xx)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9612883D0 (en) * 1996-06-20 1996-08-21 Smithkline Beecham Plc Novel compounds
US6348455B1 (en) 1998-11-23 2002-02-19 Sepracor Inc. Desmetylolanzapine compositions and methods
CA2352611A1 (en) 1998-11-23 2000-06-02 Sepracor Inc. 2-hydroxymethylolanzapine compositions and methods
AU757870B2 (en) * 1998-11-23 2003-03-06 Sepracor, Inc. Pharmaceutical compositions containing olanzapine-N-oxide
JP2003525865A (ja) 1999-03-18 2003-09-02 チルドレンズ・ホスピタル・リサーチ・ファウンデイション 非定型抗精神病薬の投与による神経性過食症および関連摂食障害の治療方法
JP2003500353A (ja) * 1999-05-19 2003-01-07 アストラゼネカ・アクチエボラーグ 処置方法
WO2005013969A1 (en) * 2003-07-15 2005-02-17 Janssen Pharmaceutica N.V. Antipsychotic agent with socializing properties

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SE9500998D0 (sv) * 1995-03-19 1995-03-19 Haakan Wilhelm Wikstroem New sulfone ester analogues of iso-clozapine and related structures: atypical neuroleptics

Also Published As

Publication number Publication date
WO1998004289A3 (en) 1998-03-19
IL128219A0 (en) 1999-11-30
NO990322L (no) 1999-03-24
CO5031292A1 (es) 2001-04-27
CZ23799A3 (cs) 1999-06-16
ZA976593B (en) 1999-01-25
AU725817B2 (en) 2000-10-19
AU4297297A (en) 1998-02-20
GB9615767D0 (en) 1996-09-04
KR20000029564A (ko) 2000-05-25
WO1998004289A2 (en) 1998-02-05
NZ333813A (en) 2000-07-28
HUP9903619A3 (en) 2001-03-28
HUP9903619A2 (hu) 2000-10-28
CA2261813A1 (en) 1998-02-05
PL331426A1 (en) 1999-07-19
EP0936924A2 (en) 1999-08-25
CN1230894A (zh) 1999-10-06
NO990322D0 (no) 1999-01-25
AR008083A1 (es) 1999-12-09
BR9710568A (pt) 1999-08-17
JP2000516924A (ja) 2000-12-19

Similar Documents

Publication Publication Date Title
TR200101398T2 (tr) Pirolidin türevleri-CCR-3 reseptörü antagonistleri.
TR199802284T2 (xx) Dopamin D3 resept�rlerinin mod�lat�rleri olarak tetrahidroizokuinolin t�revleri.
PT935465E (pt) Compostos novos de imidazole substituido
TR199902033T2 (xx) Diyabet i�in s�lfonilura-glitazon sinerjik kombinasyonlar�.
TR200001218T2 (tr) İkameli karboksamidotiazoller, bunların üretimi ve bunları içeren farmasötik bileşimler.
FI962154A (fi) Koostumus terapeuttisten tuotteiden in vivo valmistusta varten
TR199802423T2 (xx) Konsantre antikor terkibi.
YU83600A (sh) Adenozin a3 receptorski modulatori
ES2184800T3 (es) Uso de agentes anti-vegf en el tratamiento de la endometriosis.
UA41316C2 (uk) Трициклічні похідні піролу і фармацевтичний препарат
PT1093819E (pt) Compostos e composicoes para fornecimento de agentes activos
DE69501591D1 (de) Lactobazillusstämme menschlichen ursprungs, ihre zusammensetzung und deren verwendung
BR9506936A (pt) Derivados de quinazolina substituídos com 4-heterociclila processos para sua preparaçao e seu uso como agentes anticancerosos
TR200100299T2 (tr) Tedavi edici biaril türevleri.
TR199902383T2 (xx) Yeni pirimidin t�revleri ve bunlar�n haz�rlanmas� i�in proses.
ES2190246T3 (es) Nuevos compuestos de tiazolopirimidina.
PT839143E (pt) Compostos de tetralina com actividade mdr
TR199902334T2 (xx) Psikotik bozukluklar�n tedavisi veya profilaksisi i�in mirtazapin ve antipsikotik ajanlar�n yeni terap�tik kombinasyonlar�.
BR9909486A (pt) Compostos calcilìticos
DE69522188T2 (de) Verwendung von Substanz P Antagonist im pharmazeutischer Zusammensetzung
TR199900140T2 (xx) 5HT2C antagonist ve bir D2 antagonist ihtiva eden farmas�tik bile�imi.
PT101444A (pt) Associacao sinergizante com efeito antagonista dos receptores nk1 e nk2, uso de produtos com actividade antagonista dos receptores nk1 e nk2 na sua preparacao e composicao farmaceutica contendo a referida associacao
TR199900872T1 (xx) Bir heteroetinilen radikali ile ba�l� bi-aromatik bile�ikler ve bunlar� ihtiva eden farmas�tik ve kozmetik kompozisyonlar.
CL2002001701A1 (es) Uso de al menos un compuesto seleccionado entre melatonina, agentes melatoninergicos, agonistas y antagonistas de melatonina, en una cantidad de 0,0025-50 mg, para preparar un medicamento util para el tratamiento y mejora de la calidad repadora del sueno.
ATE332728T1 (de) Photoempfindliche sonnenschutzmittel